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PREFACE 
A tandem reduction-reductive amination sequence has been developed for the 
synthesis of benzo-fused substituted heterocycles incorporating two heteroatoms. The 
heterocycles synthesized by this method are 2,3,4,5-tetrahydro-1,5-benzoxazepines and 
2.3A..5-tetrahydro-1H-l,5-benzodiazepines. These compounds have a broad range of 
biological activities. The key step in the synthesis of these heterocycles is the tandem 
reduction-reductive amination reaction involving a catalytic reduction of an aromatic 
nitro group followed by an intramolecular reductive amination with a pendant ketone or 
aldehyde substituent. This method for synthesizing 2,3,4,5-tetrahydro-1,5-
benzoxazepines and 2,3,4,5-tetrahydro-IH-1.,5-benzodiazepines has been shown to give 
higher yields than previous methods in the literature. The present work demonstrates that 
the tandem reduction-reductive amination reaction provides a new route to seven-
membered heterocycles., allowing a wide variety of substitution patterns. 
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CHAPTER I 
EARLY SYNTHESES OF TETRAHYDR0-1,5-BENZOXAZEPINES 
AND TETRAHYDRO-lH-1,5-BENZODIAZEPINES 
Introduction 
Heterocycles are important compounds for developing new drugs in the 
pharmaceutical industry. Most biologically active compounds have at least one 
heterocyclic ring as part of their structure. There will always be an interest in developing 
new strategies to prepare heterocycles that are more efficient or less costly than known 
methods. Routes to heterocycles with new substitution patterns not previously accessible 
are important for drug discovery. This chapter describes early syntheses of two families 
of heterocycles incorporating two heteroatoms, 2,3,4,5-tetrahydro-1,5-benzoxazepines 
and 2,3,4,5-tetrahydro-l H-1,5-benzodiazepines. 
2,3,4,5-Tetrahydro-l ,5-Benzoxazepines 
Members of the 1,5-benzoxazepine family of compounds have a number of 
pharmacological uses. Among them include uses as central nervous system depressants, 1 
as orexin receptor antagonists for the treatment of obesity and sleep disorders, 2 and as 
angiotensin converting enzyme-inhibitors3 for the treatment of cardiovascular disease. 
The pharmacological possibilities for 1,5-benzoxazepines have led to an interest in their 
current synthesis and possibly more improved syntheses. 
1 
The first reported method for synthesizing 2,3,4,5-tetrahydro-l,5-benzoxazepine 
was in 1 921 by von Braun and Braunsdorf (Figure I) and started with amino ester 1. 
Saponification of the ester group gave alcohol 2 and treatment with hydrochloric acid 
resulted in cleavage of the aryl ether as well as conversion to chloride 3. Treatment of 3 





















Figure 1. First reported synthesis of 2,3,4,5-tetrahydro-1,5-benzoxazepine. 
The major disadvantage of this method for synthesizing benzoxazepines was the low 
overall yield ( 10% ). Another potential limitation was that the halide could undergo an 
elimination reaction at high temperatures instead of a substitution reaction, preventing 
cyclization. 
Sidhu, Thyagarajan and Bhalerao5 synthesized 2,3,4.,5-tetrahydro-1-5-
benzoxazepine by two different methods, with the intent of improving on Braun .. s 
method. In the first approach (Figure 2), 2-aminophenol (5) was condensed with 3-
chloropropionyl chloride to give 6. Compound 6 was then cyclized with potassium 
2 
methoxide to give amide 7 and carbonyl reduction with lithium aluminum hydride gave 









Figure 2. 1,5-Benzoxazepine by cyclization followed by amide reduction. 
This method has one of the same limitations as von Braun's method, where there could 
be an elimination reaction, but the yield was much higher, around 55% overall yield. 
The second method developed by Sidhu and co-workers also used 2-aminophenol 
(5) as the starting material (Figure 3). Alkylation of 5 at the nitrogen with l-bromo-3-
chloropropane gave 8 which was cyclized by an SN2 reaction to give the 2,3,4,5-
tetrahydro-1,5-benzoxazepine. This method could still undergo an elimination reaction., 
but it has fewer steps than the other syntheses. 
5 4 
8 
Figure 3. 1 .. 5-Benzoxazepine by SN2 cyclization. 
3 
Unfortunately, this synthesis only gave 40% overall yield. Thus, while the acylation 
method reported by Sidhu and co-workers had one extra step, it gave the desired 
heterocycle in higher yield. 
Nagarajan and co-workers6 synthesized a benzoxazepine by another route (Figure 
4 ). Amide 9 was cyclized by nucleophilic aromatic substitution under basic conditions to 
give benzoxazepinone 10. The amide carbonyl in 10 was then reduced to give the target 
heterocycle. This method suffered from two problems: (1) the starting material was not 






Figure 4. 1,5-Dibenzoxazepinone by SN2 cyclization. 
Nour El-Din and Shawki7 developed a strategy for synthesizing 2,3,4,5-
tetrahydro-l,5-benzoxazepine that began with 2-nitrophenol (11) (Figure 5). The phenol 
was 0-alkylated with l-bromo-3-chloropropane to give ether 12. The nitro group of 12 
was then reduced to an amine under acidic conditions to produce the amine hydrochloride 
13 which was reacted with formic acid to produce amide 14. Finally, cyclization of 14 





















When compared to the two previous methods of Sidhu and co-workers, the yield was 
very low ( 15% ), making this a less attractive method for preparing benzoxazepines. 
Sam1 developed a strategy for synthesizing benzoxazepines from 3-(3-
chloropropyl)benzoxazolin-2-one (15) (Figure 6). Compound 15 was not commercially 
available and had to be synthesized, but details of the procedure and yields were not 
reported. Compound 15 was refluxed in 2-methoxyethanol in the presence of potassium 
hydroxide to give 2,3,4,5-tetrahydro-l ,5-benzoxazepine in 55% yield. Sam also 
synthesized the N-acylated benzoxazepine 17 by reacting 15 with pyrrolidine. This 











Figure 6. Cyclization to form a 1,5-benzoxazepine and an acylated 1,5-benzoxazepine. 
Finally" Sebok, Levai and Timar8 synthesized 2,3,4,5-tetrahydro-1,5-
benzoxazepine through a Beckmann rearrangement (Figure 7). Benzochromanone 18 
was converted to the oxime 19 in 93% yield using hydroxylamine hydrochloride and 
base. The oxime was then reduced with lithium aluminum hydride to give a mixture of 
the 4-aminochroman 20 and 2,3,4,5-tetrahydro-1,5-benzoxazepine in 8% and 38% yields, 
respectively. The benzoxazepine was the major product, but the yield was modest (38%). 
The authors also reported a case where the carbon alpha to the oxygen was substituted 
with two methyl groups and the carbon on the aryl group meta to the oxygen was 
substituted with a methoxy group. The yield for the benzoxazepine from this substrate 
was lowered to 25%, while the aminochroman increased to 20%. This demonstrated a 
limitation in the ability to substitute the benzoxazepine. As the carbon next to the oxygen 
is more heavily substituted, the benzoxazepine is produced in lower yield, increasing the 
amount of aminochroman. 
6 
0 N .... OH 
c6 NH20H x HCI c6 LiAIH4 K2C03, EtOH Ether 0 0 
18 19 
co + 4 
20 
Figure 7. 2,3,4,5-Tetrahydro-1,5-benzoxazepines by Beckmann rearrangement. 
2,3,4,5-Tetrahydro-lH-1,5-Benzodiazepines 
The 1,5-benzodiazepines express a broad spectrum of biological activity. They 
have activity as antihypertensives because they are used as arginine vasopressin (A VP) 
antagonists.9 .1° A VP acts on the vasculature to produce a hypertensive effect, so a 1,5-
benzodiazepine acting as an A VP antagonist is an antihypertensive. A VP also acts on the 
kidneys to increase water retention, so a 1,5-benzodiazepine acting as an A VP antagonist 
could also be used for treatment of diseases with conditions characterized by polyuria 
(excessive urine production). Benzodiazepines act as cholecystokinin-B (CCK-B) 
antagonists 11 and thus can be used as a treatment for nervous tension and anxiety. 12 1.,5-
benzodiazepines have also been found to have activity as antimicrobials,' 3 analgesics, 14· 15 
anticonvulsants, 14.l 5 antiaggressives, 14 antiinflammatories, 16 and antidepressants. 17 
Because of the many pharmacological uses of 1,5-benzodiazepines, there is a continuing 
7 
interest m developing new and improved syntheses that yield rings bearing new 
substitution patterns. 
In 1943 .. Bachman and Heisey 18 synthesized a 1,5-benzodiazepine while trying to 
prepare 2-vinylbenzimidazole (24) (Figure 8). The starting material used was 1,2-
phenylenediamine (21). Compound 21 was reacted with acrylic acid (22) to give 2,3,4,5-
tetrahydro-l.,5-benzodiazepin-2-one (23) in 67% yield. Though the authors did not 
reduce amide 23, this route constitutes one of the first successful syntheses of the 












Figure 8. 1,5-Benzodiazepinone by condensation of acrylic acid with 1,2-
phenylenediamine. 
Dandegaonker and Desai 19 synthesized several 1.,5-benzodiazepin-2-ones by 
reaction of 1,2-phenylenediamene (21) with a series of substituted cinnamic acids. The 
authors proposed a mechanism (Figure 9) involving acylation of 21 followed by 
conjugate addition to the a,(3-unsaturated amide. The target heterocycles were produced 
in 25-77% yields. 
8 
0 











Figure 9. Mechanism for reaction of a,~-unsaturated acid with 1,2-phenylenediamine. 
Hasan and co-workers20 formed 1,5-benzodiazepines by the same method as 
Dandegaonker and Desai, only they varied the substitution on the aliphatic carbons of the 
diazepine ring by reacting 1,2-phenylenediamine with four different a.,~-unsaturated 
acids: crotonic, methacrylic, 3,3-dimethylacrylic and acrylic acids (Figure I 0). The 
products of these reactions would place methyl groups on two of the carbons in the 
diazepine ring. The amide products were converted to 1,5-benzodiazepines (3 la-d) by 
reduction with lithium aluminum hydride. The final compounds were isolated in 25-40% 











N-fRR:2 H R3 
30 
cc;i:, 
31a: R1 = R2 = H R3 = CH3 
b: R2 = R3 = H R 1 = CH3 
c: R 1 = H R2 = R3 = CH3 
d: R1 = R2 = R3 = H 
31a-cl 
Figure 10. Condensation of various a,~-unsaturated acids with 1,2-phenylenediamine. 
Zhelyazkiv and Bizhev21 synthesized 1,5-benzodiazepines starting with a,~-
unsaturated ketones rather than a,~-unsaturated acids (Figure 11 ). The starting material 





~ R CCN~R1 
N===·C R 
33 
Figure 11. Condensation of a,~-unsaturated ketone with 1,2-phenylenediamine. 
were either methyl or phenyl. The yields for these products were as high as 78%. Final 
reduction of the C=N could be carried out with sodium borohydride as Orlov and co-
10 
workers22 did with a similar 1,5-benzodiazepine (Figure 12). The method of Zhelyazkov 
and Bizhev, however, allowed a wider variety of substitution patterns. 
~ Ph 
C() C(H~=r 
Ph H Ph 
34 35 
Figure 12. Reduction of C=N with NaB~. 
Contreras and co-workers23 synthesized 1,5-benzodiazepines by double reductive 
condensation of 1,2-phenylenediamine dihydrochloride with two equivalents of a series 
of symmetrical ketones (Figure 13 ). Reaction in the presence of sodium borohydride 
gave two products. The major product was the desired 1,5-benzodiazepine; the minor 






36 37 38 39 
Figure 13. 1,5-Benzodiazepines by reductive condensation with two ketones. 
The R groups included methyl, cyclopentyl, cyclohexyl and cycloheptyl. The desired 
1,5-benzodiazepines were produced in 50-68% yield. When an aromatic ketone or 
aldehyde was used, the 1,5-benzodiazepines were not obtained. 
11 
Misiti. Gatta, and Landi-Vittory24 synthesized benzodiazepines by utilizing the 
Schmidt reaction (Figure 14). The authors began with tetrahydroquinolin-4-one (40). A 
nitrogen was inserted adjacent to the carbonyl using the Schmidt reaction and the 
resulting amide was reduced to the secondary amine with lithium aluminum hydride. The 
Schmidt reaction yielded a mixture of two products., a 1,4-benzodiazepine and a 1,5-
benzodiazepine in 80-95% yield. Unfortunately, the major product in most of the 
reactions was the 1,4-benzodiazepine. There were only three cases out of ten where the 
1.5-benzodiazepine predominated (Table I). The 1,5-benzodiazepine was the major 
product only when the R1 substituent on the nitrogen was an acyl group. Thus, the 
Schmidt reaction is not ideal for synthesizing 1,5-benzodiazepines, unless an acyl group 
is required on the nitrogen. 
0 R2m I~ 












Figure 14. Benzodiazepines by the Schmidt reaction. 
12 
43a-j 
1,2,3 ,4-tetrahdroq uino lin-4-ones isomer ratio 
% aryl % alkyl 
Rt R2 R3 % yield migration migration 
40a H H H 88 20 80 
40b Me H H 82 25 75 
40c Ph H H 90 5 95 
40d Ac H H 85 95 5 
40e H H OMe 95 30 70 
40f Me H OMe 92 35 65 
40g Ac H OMe 90 90 10 
40h H Cl H 92 35 65 
40i Me Cl H 91 25 75 
40j Ac Cl H 80 90 10 
Table I. Migratory aptitudes in the Schmidt reaction of tetrahydroquinolin-4-ones. 
13 
CHAPTER II 
SYNTHESIS OF 2,3,4,5-TETRAHYDR0-1,5-BENZOXAZEPINES 
AND 2,3,4,5-TETRAHYDRO-lH-1,5-BENZODIAZEPINES 
Introduction 
The nitro group has proven useful as a latent amine m reductive amination 
reactions under hydrogenation conditions.25 Nitro groups are easily reduced to amines by 
catalytic hydrogenation. The resulting amines can then react with an aldehyde or ketone 
present in the molecule to form nitrogen heterocycles. The tandem reduction-reductive 
amination reaction is the reduction of an aromatic nitro group to the amine followed by 
reductive amination with an intramolecular aldehyde or ketone, all under hydrogenation 
conditions. 
Prior work has shown the tandem reduction-reductive amination reaction to be 
useful in forming nitrogen heterocycles with more that one heteroatom. Bunce and co-
workers25 have developed a route to tetrahydrobenzoxazines and tetrahydroquinoxalines 
based on this strategy (Figure 15). Cyclization substrates were prepared by removal of 
the acidic proton from 2-nitrophenol and N-(2-nitrophenyl)acetamide and alkylation at 
the oxygen or the nitrogen, respectively, with an allylic bromide. The resulting alkene 
was ozonized to give the ketone or aldehyde and hydrogenation effected the tandem 
reduction-reductive amination to give the target heterocycles. 
14 
1 
1) NaH, THF 
2)Br~ 
R 




X = 0, N-COCH3 
2 






Figure 15. Synthesis of tetrahydrobenzoxazines and tetrahydroquinoxalines. 
In the present work, the tandem reduction-reductive amination reaction has been 
extended to the synthesis of 2,3,4,5-tetrahydro-l ,5-benzoxazepines and 2,3,A.,5-
tetrahydro-l H-1,5-benzodiazepines (Figure 16). Members of these heterocycle families 
have shown a wide range of biological activity and thus may have potential as new 











Sa R= H 
b R = CH3 
c R = C4H9 
d R = t-C4H9 
e R = CsHs 
2,3,4,5-tetrahydro-1 H-1,5-benzodiazepines 
6a R= H 
b R = CH3 
Figure 16. Target molecules of the current project. 
Proposed Route to 2,3,4,5-Tetrahydro-1,5-Benzoxazepines 
and 2,3,4,5-Tetrahydro-lH-1,5-Benzodiazepines 
The current project for synthesizing 2,3,4,5-tetrahydro-1,5-benzoxazepines and 
2,3,4,5-tetrahydro-IH-l,5-benzodiazepines required the preparation of substrates such as 
8 (Figure 17). Bunce and Johnson26 have previously demonstrated that the tandem 
reduction-reductive amination reaction can be used to prepare seven-membered rings 
containing one heteroatom and thus the primary challenge was the synthesis of the 
cyclization substrates. The initial target was alkene 7. Ozonolysis of 7 would yield the 
ketone 8. Reductive cyclization of 8 would then afford the target heterocycle 9. 
16 
1) 03, CH30H 
2) (CH3)2S, 
p-TsOH 
H2, 5% Pd/C 





Figure 17. Proposed route to the target molecules. 
The first synthetic approach to 7 involved alkylation of 2-nitrophenol (12) with a 
homoallylic halide (Figure 18). Because the homoallylic halides are less reactive than 
their allylic counterparts, bromide 10 was converted to iodide 11. Deprotonation of 12 
with sodium hydride in tetrahydrofuran then gave the anion which was reacted with 11. 
Workup of the reaction did not afford the expected ether, however, but instead gave 
starting material 12. This reaction failed because the iodide underwent an elimination 
reaction and 1,3-butadiene evolved out of the mixture as a gas. Similarly, attempted 
alkylation of amide 14 gave the same elimination process. Thus, another method for 
forming the required alkenes 7 was necessary. [Note: We later found that potassium 
carbonate in acetone could be used to alkylate the phenol, but this base was ineffective in 




















Figure 18. Attempted alkylation of 2-nitrophenol and N-(2-nitrophenyl)acetamide. 
Synthesis of 2,3,4,5-Tetrahydro-1,5-Benzoxazepine and 
2,3,4,5-Tetrahydro-lH-1,5-Benzodiazepine Precursors 
The successful method for preparing the 1,5-benzoxazepine precursors l 8a-e was 
carried out in two steps. Nucleophilic aromatic substitution of the homoallylic alkoxides 
from 15a-e with 2-fluoro-1-nitrobenzene27 (16) afforded alkenes l 7a-e in 83-95% yield 






2) (CH3)2S, p-TsOH 
3) 3% HCI04:THF (1:1) 










a R= H 
b R = CH3 
c R = C4Hg 
d R = t-C4H9 
e R = C5H5 
Figure 19. Synthesis of 1,5-benzoxazepine precursors. 
Two of the necessary homoallylic alcohols (15a and 15b) were commercially 
available; the others (15c, 15d and 15e) required synthesis. It was decided that the 
required homoallylic alcohols could be most easily prepared from allylic bromides that 
were available from an earlier project. The synthesis of these allylic bromides is shown 
in Figure 20. For the n-butyl case, alkyne 19 was hydrobrominated30 to give alkene 20 in 
70% yield. Compound 20 was converted to its Grignard reagent and reacted with 
formaldehyde to give allylic alcohol 21 in 65% yield. The allylic alcohol was then 
treated with phosphorus tribromide to give the allylic bromide 22c in 88% yield.31 The 
tert-butyl case was prepared by brominating32 alkene 23 with N-bromosuccinimide to 

















Figure 20. Synthesis of allylic bromides. 
The methods by which the homoallylic alcohols were prepared from the allylic bromides 
are illustrated in Figure 21. The butyl and tert-butyI cases were synthesized by 
converting allylic bromides 22c-d into Grignard reagents and reacting them with solid 
carbon dioxide. For this reaction it was necessary to use activated Rieke magnesium33 to 
suppress coupling during the formation of the Grignard reagent. Standard Grignard 
conditions afforded the carboxylic acids in 20-25% yields with the bulk of the product 
resulting from coupling. Generation of the Grignard reagent using Rieke magnesium at 
0°C'I however, permitted formation of the acid products in 68-71 % yield with no 
significant coupling of the allylic halide. The resulting carboxylic acids 24c-d were 
reduced with lithium aluminum hydride to give the desired homoallylic alcohols 15c-d in 
95-96% yield. Synthesis via the carboxylic acids was superior to direct synthesis of the 
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alcohols by reaction with formaldehyde. The yield of the acid was higher and the product 
was readily purified by extraction. Finally, the phenyl case was prepared by reacting 25 
with formaldehyde in acetic acid and acetic anhydride to give 26 by an ene reaction. 34 
The acetate 26 was hydrolyzed to give homoallylic alcohol 15e in 50% overall yield. 
R = H, CH3 (Commercially Available) 
R 
~OH 
15a R = H 
b R = CH3 
R 
~Br 
22c R = n-C4H9 
d R = t-C4H9 




1) Rieke Mg, THF 1) LiAIH4 
2) CO2 (s) 
24c-d 
HCHO CsHs 1M KOH 
HOAc ~OAc EtOH:H20 
Ac20 (1: 1) 
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The 1,5-benzodiazepine precursors required homoallylic amines as substrates. 
Homoallylic amines can be most easily prepared from allyl cyanides 27a and 27b: 27a is 
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commercially available but 27b is not. The method by which the ammes were 
synthesized is illustrated in Figure 22. To extend the carbon chain of the allylic bromide 
28b by one carbon, 28b was reacted with copper cyanide35 to give 27b in 80% yield. The 
cyano group of 27b was then reduced36 with lithium aluminum hydride/aluminum 








27a R = H 
b R = CH3 
CuCN 
125 °c, 2 h 
80% 
1) LiAIH4, AICl3, ether 






Figure 22. Synthesis of homoallylic amines. 
The substrates required for synthesizing the 1,5-benzodiazepines were more 
difficult to prepare (Figure 23) than the substrates for the 1,5-benzoxazepines. 
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Homoallylic amine 29a was reacted with 2-fluoro-1-nitrobenzene (16) by a nucleophilic 
aromatic substitution reaction to give 30a. Acylation of this amine was necessary to 
H2N~ 16 








2) (CH3)2S, p-TsOH 
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a R= H 
No 
Reaction 
b R = CH3 
Figure 23. Synthesis of 1,5-benzodiazepine precursors. 
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prevent N-oxidation during the ozonolysis, but attempts to acylate 30a failed. Because 
the first approach did not work, a new route was developed. The homoallylic amines 
(29a-b) were acylated with benzoyl chloride (31) to give benzamides 32a-b in 90-95% 
yield.37 Deprotonation of the benzamides with sodium hydride, followed by reaction 
with 16~ gave the desired substrates 34a-b in 52-58% yield by a nucleophilic aromatic 
substitution.38 To our knowledge, this is the first example of the nucleophilic aromatic 
substitution of a benzamide on an aromatic system. Amides 34a-b were then ozonized to 
give 35a-b in 88-95% yield. 
Syn thesis of 2,3,4,5-Tetrahydro-l ,5-Benzoxazepines and 2,3,4,5-Tetrahydro-lH-1,5-
Benzodiazepines by a Tandem Reduction-Reductive Reaction 
The precursors 18a-e and 35a-b were used in the tandem reduction-reductive 
amination reaction to produce the target heterocycles. The results of this reaction are 
illustrated in Figure 24. When R =Hor CH3, the yields were high, ranging from 70-88% 
yield for both the 1,5-benzoxazepine and 1,5-benzodiazepine targets. The butyl, tert-
butyl, and phenyl cases were done only for the 1,5-benzoxazepine targets. The butyl case 
proceeded normally to give a 78% yield of the 1,5-benzoxazepine. The tert-butyl and 
phenyl cases gave disappointing results with 37% and 0% yields, respectively. 
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5a R = H 82% 
5b R = CH3 70% 
Sc R = C4Hg 78% 
5d R = t-C4Hg 37% 
Se R = CsHs 0% 
0 ~Ph 
3Sa-b 
H2, 5% Pd/C C() 
H R 
Sa-b 
Sa R= H 82% 
Sb R = CH3 88% 
Figure 24. Results of the tandem reduction-reductive amination reaction. 
The yield in the synthesis of the parent 1,5-benzoxazepine (R = H) was dependent 
on the concentration of the substrate (Figure 25). When the concentration of the substrate 
was 3 .85 x I 0-2 M, the desired target was produced in 72% yield and dimer 36 was 
isolated in 3.5% yield. When the concentration was reduced by a factor of three, 
however, the reaction gave a higher yield of the desired product (82%) and dimer 
formation was almost undetected. Thus, when the solution is more dilute, the chance for 
an intermolecular reaction decreased, and most of the product derived from the 
intramolecular reaction. 
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The tert-butyl case had a relatively low yield when compared to the prior cases. 
The reaction gave two products (Figure 25). The 1,5-benzoxazepine was produced in 
3 7% yield and the amino ketone 37 was produced in 49% yield. Compound 37 is a result 
of nitro group reduction without subsequent cyclization. Presumably, reductive 
cyclization was precluded by the steric hindrance from the tert-butyl group. 
Yield at 
Substrate Concentration (M} 
3.85 X 10-2 1.28 X 10-2 
H2, 5% Pd/C 
5a 72% 82% 
+ 
18a 








Figure 25. Results of R = H, t-C4H9 cases for 1.5-benzoxazepines. 
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The substrate having R = C6H5 gave no ring closure when the precursor was 
subjected to the tandem reduction-reductive amination reaction (Figure 26). Instead of 
the desired 15-benzoxazepine target, compound 38 was produced. Compound 38 is the 
result of both nitro and carbonyl reduction. Evidently, the phenyl ketone in 18e is highly 
susceptible to reduction and was reduced before it could react with the amine. Thus, 
there was no cyclization. By comparison, Bunce and co-workers successfully performed 
a tandem reduction-reductive amination reaction on a substrate that produced a six-
membered heterocycle 39. In this reaction, the ring closure proceeded easily to give 40 
in 76% yield. 
C(~ 
02N O CsHs 
H2, 5% Pd/C Qo~ 
H
2
N HO C5H5 
18e 38 
84% 
H2, 5% Pd/C 
39 
76% 
Figure 26. Tandem reduction-reductive amination: comparison of seven-membered vs. 
six-membered ring closure for R = C6Hs. 
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A mechanism for the tandem reduction-reductive amination reaction is illustrated 
in Figure 27. The precursor (18a-e, 35a-b) first undergoes a reduction of the nitro group 
under catalytic hydrogenation conditions with the loss of water to give 41. Once the nitro 
group is reduced to an amine, the unshared pair of electrons on the nitrogen attacks the 
carbonyt closing the ring to give 42. Elimination of water occurs to form imine ( 43) and 
addition of another equivalent of hydrogen gives the target molecule (5a-e, 6a-b). 
o:) 3 H2 X X g£)R cc~R Pd/C 02N R (-2 H20) 
Hr-OH 
1 Sa-e, 35a-b 41 42 
X=O 






43 Sa-e, 6a-b 
Figure 27. Mechanism for tandem reduction-reductive amination reaction. 
Conclusions 
A new route has been developed to two potentially valuable ring systems. From 
the homoallylic alcohols, 2,3,4,5-tetrahydro-l ,5-benzoxazepines were synthesized in 
three steps with an average of 66% yield. From the homoallylic amines~ 2,3A,5-
tetrahydro-l H-1,5-benzodiazepines were synthesized in four steps with an average of 
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42% yield. This latter synthesis features a new approach to the synthesis of the 
cyclization substrates involving nucleophilic aromatic substitution of a secondary 
benzamide to 2-fluoro-1-nitrobenzene to install the entire prefabricated nitrogen side 
chain onto the aromatic ring. The tandem reduction-reductive amination reaction 
provides an efficient, high-yield route to seven-membered heterocycles. The larger rings 
are formed more slowly, however, allowing competitive reactions to intervene in some 
cases. The nitro group continues to prove useful as a latent amine in reductive amination 
reactions under hydrogenation conditions. A wider variety of substitution patterns is 
available using the current synthetic approach compared to prior methods. 
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Experimental 
All reactions (except hydrogenations) were run under dry nitrogen in oven-dried 
glassware. The ammonium chloride (saturated), 1 M hydrochloric acid, 0.2 M sodium 
hydroxide.. sodium bicarbonate (saturated) and sodium chloride (saturated) used in 
various work-up procedures were aqueous solutions. All temperatures are reported in °C. 
Reactions were monitored by thin layer chromatography on silica gel GF plates (Analtech 
no. 21521) with ultraviolet detection. Preparative separations were performed using one 
of the following methods: (1) flash column chromatography39 on silica gel (grade 62, 60-
200 mesh) containing ultraviolet-active phosphor (Sorbent Technologies, UV-5) packed 
into quartz columns or (2) preparative thin layer chromatography on 20-cm x 20-cm 
silica gel GF plates (Analtech no. 02015). Band elution for both methods was monitored 
using a hand-held ultraviolet lamp. Melting points were uncorrected. Infrared spectra 
were run as thin films on sodium chloride disks and referenced to polystyrene. 1H and 
13C Nuclear magnetic resonance spectra were· measured in deuteriochloroform at 300 
MHz and 75 MHz, repectively, using tetramethylsilane as an internal standard; coupling 
constants (J) are given in Hz. Mass spectra ( electron impact/direct probe) were obtained 
at 70 electron volts. 
Compounds 15a (3-buten-1-ol) and 15b (3-methyl-3-buten-1-ol) were 
commercially available. Compound 15e (3-phenyl-3-buten-1-ol) was prepared by the 
method of Hawkins and Thompson;34 the physical and spectral data for 15e matched 
those reported in the literature.4° Compounds 22a and 22b were commercially available; 
compounds 22c and 22d were prepared as described previously.28 Compound 27a (allyl 
cyanide or 3-butenenitrile) was also commercially available. 
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Representative Procedure for the Preparation of 3-Butenoic Acids: 3-Butyl-
3-butenoic Acid (24c). This compound was prepared on a 20-mmole scale by 
carbonation of the Grignard reagent from 22c generated using activated magnesium 
described by Rieke and Bales.33 A suspension of 3.80 g (40.0 mmole) of anhydrous 
magnesium chloride, 3.32 g (20.0 mmole) of potassium iodide and 2.72 g (70.0 mmole) 
of freshly cut potassium metal in 100 mL of dry tetrahydrofuran was prepared under 
nitrogen in a 250-mL three-necked round-bottomed flask. The mixture was refluxed with 
vigorous stirring for 3 hours to give a black viscous suspension. The activated 
magnesium was cooled to 0° and 3.54 g (20.0 mmole) of 22c was added dropwise with 
vigorous stirring. Stirring was continued for 45 minutes at 0° and the Grignard reagent 
was transferred by cannula under nitrogen pressure to a large excess of solid carbon 
dioxide in a 500-mL three-necked round-bottomed flask. The reaction was stirred for 3 
hours, quenched with ammonium chloride, acidified to pH 2 with 1 M hydrochloric acid 
and extracted with ether (three times). Purification by base extraction (0.2 M sodium 
hydroxide)-reacidification (1 M hydrochloric acid) afforded 1.93 g (68%) of 3-butyl-3-
butenoic acid as a colorless oil. The product was carried on without further purification. 
IR: 3686-2287, 1710, 1646, 899 cm·•; 1H NMR: o 11.0 (br s, 1 H), 4.96 (m, 1 H), 4.93 
(m, 1 H)'I 3.08 (d, 2 H, J= 0.8), 2.13 (t, 2 H, J= 7.1), 1.44 (m, 2 H), 1.33 (m, 2 H), 0.91 
(t, 3 H, J = 7.4); 13C NMR: o 178.2, 142.0, 114.0, 41.7, 35.5, 22.3, 13.9; MS: mlz 142 
(M+). 
Anal. Calcd. For CsH140 2: C, 67.61; H, 9.86. Found: C, 67.91; H, 9.92. 
3-tert-Butyl-3-butenoic Acid (24d). This compound (2.02 g, 71 %) was isolated 
as a colorless oil and was used without further purification. IR: 3467-2382, 1710 .. 1636 .. 
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908 cm- 1: 1H NMR: 8 11.6 (br s, 1 H), 5.10 (s, 1 H), 4.93 (s, 1 H), 3.11 (s, 2 H), 1.09 (s, 9 
H): 13C NMR: 8 179.2, 149.8, 112.0, 38.1, 36.3, 28.8 (3); MS: mlz 142 (M+). 
Anal. Calcd. for C8H140 2: C, 67.61; H, 9.86. Found: C, 67.51; H, 9.92. 
Representative Procedure of 3-Buten-1-ols: 3-Butyl-3-buten-l-ol (15c). 
Reduction of the 2.10 g (14.8 mmoles) of 24c with 0.56 g (14.8 mmoles) of lithium 
aluminum hydride in 50 mL of anhydrous ether afforded the crude alcohol after workup 
with 5% aqueous sodium hydroxide and water. Purification by vacuum distillation 
afforded 1.80 g (95%) of 15c as a colorless liquid, bp 46-48° (2 mm Hg); IR: 3338, 1643, 
885 cm-1: 1H NMR: 8 4.86 (s, 1 H), 4.81 (s, 1 H), 3.71 (br t, 2 H, J= 6.6), 2.30 (t, 2 H, J 
= 6.3) .. 2.03 (t, 2 H, J= 6.9), 1.50-1.24 (complex, 5 H), 0.91 (t, 3 H, J= 7.2); 13C NMR: 8 
146.2 .. 108.5 .. 60.3, 39.1, 35.4, 29.9, 22.4, 13.9; MS: m/z 128 (M+). 
Anal. Calcd. for C8H160: C, 75.00; H, 12.50. Found: C, 74.94; H, 12.55. 
3-tert-Butyl-3-buten-1-ol (15d). This compound (1.61 g, 96%) was isolated as a 
colorless liquid by the same procedure used to prepare 15c, bp 60-62° (18 mm Hg); IR: 
3339 .. 1633, 892 cm-1; 1H NMR: o 4.98 (s, 1 H), 4.74 (s, 1 H), 3.77 (br t, 2 H, J = 6.0), 
2.35 (t .. 2 H, J= 6.7), 1.59 (hrs, 1 H), 1.08 (s, 9 H); 13C NMR: o 154.1, 107.8, 61.9, 36.3, 
31.0, 29.3 (3); MS: mlz 128 (M+). 
Anal. Calcd. for C8H 160: C, 75.00; H, 12.50. Found: C, 75.08; H, 12.54. 
Representative Procedure for the Preparation of 3-Butenyl(2-nitroaromatic) 
Ethers: 2-(3-butenyloxy)-1-nitrobenzene (17a). This compound was prepared on a 
5.00-mmole scale by nucleophilic aromatic substitution of the alkoxide derived from 3-
butyl-3-buten-l-ol with 2-fluoro-1-nitrobenzene according to the procedure of Bunce and 
Easton.27 The product (0.82 g, 85%) was purified on a 40 cm x 2.5 cm silica gel column 
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eluted with 5% ether in hexane to give 0.82 g (85%) of 17a as a light yellow oil. The 
spectral data matched those reported previously.27 
2-(3-Methyl-3-butenyloxy)-l-nitrobenzene (17b). This compound (0.87 g, 
84%) was isolated as a light yellow oil by the same procedure used to prepare 17a; IR: 
1650 .. 1525.1351 cm-1; 1HNMR:67.81 (dd, 1 H,J=8.l, 1.6), 7.51 (ddd, I H,J=8.4, 
7.5 .. 1.3), 7.08(d, 1 H,J=8.4), 7.00(t, 1 H,J=8.l),4.86(s, I H),4.81 (s, 1 H),4.21 (t, 
2 H .. J = 6.8) .. 2.56 (t, 2 H, J = 6.8), 1.81 (s, 3 H); 13C NMR: 6 152.2, 141.5, 140.0, 133.9, 
125.5 .. 120.2. 114.5, 112.6, 68.4, 36.8, 22.8; MS: mlz 207 (M+). 
Anal. Calcd. for C 11 H 13N03: C, 63.77; H, 6.28; N, 6.76. Found: C, 63.89; H, 
6.34; N, 6.67. 
2-(3-Butyl-3-butenyloxy)-l-nitrobenzene (17c). This compound (1.09 g, 88%) 
was isolated as a light yellow oil by the same procedure used to prepare 17a; IR: 1645, 
1358, 1351 cm-1; 1H NMR: 6 7.81 (dd, 1 H, J= 8.1, 1.8), 7.50 (ddd, 1 H, J= 8.5, 7.5, 
1.8). 7.08 (dd, 1 H, J= 8.5, 1.0), 7.01 (ddd, 1 H, J= 8.1, 7.5, 1.2), 4.86 (s, 1 H), 4.83 (s, 1 
H) .. 4.20 (t, 2 H, J= 6.9), 2.56 (t, 2 H, J= 6.9), 2.09 (t, 2 H, J= 7.1), 1.49-1.26 (complex, 
4 H), 0.91 (t, 3 H, J = 7.1); 13C NMR: 6 152.2, 145.6, 140.2, 133.9, 125.5, 120.2, 114.3, 
111.3, 68.6, 36.1, 35.1, 29.8, 22.4, 13.9; MS: mlz 249 (MJ. 
Anal. Calcd. for C 14H19N03: C, 67.47; H, 7.63; N, 5.62. Found: C, 67.63; H, 
7.71; N, 5.47. 
2-(3-tert-Butyl-3-butenyloxy)-l-nitrobenzene (17d). This compound ( 1.07 g, 
86%) was isolated as a light yellow oil by the same procedure used to prepare 17a; IR: 
1638, 1526, 1354cm-1; 1HNMR:67.81 (dd, 1 H,J=8.l, 1.8), 7.51 (ddd, 1 H,J=8.5, 
7.5, 1.8), 7.09 (dd, 1 H, J= 8.5, 1.0), 7.01 (ddd, 1 H, J= 8.1, 7.5, I.2t 4.99 (s. 1 H) .. 4.78 
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(s. 1 H). 4.21 (t. 2 H, J = 7.5), 2.61 (t, 2 H, J = 7.5), 1.09 (s, 9 H); 13C NMR: 8 153.4, 
152.2. 140.2. 134.0. 125.5, 120.2, 114.5, 108.3, 69. 7, 36.2, 30.4, 28. 9 (3 ); MS (30 
electron volts): mlz 249 (M+). 
Anal. Calcd. for C14H19N03: C, 67.47; H, 7.63; N, 5,62. Found: C, 67.52; H, 
7.65; N. 5.57. 
2-(3-Phenyl-3-butenyloxy)-1-nitrobenzene (17e). This compound (1.21 g, 90%) 
was isolated as a light yellow oil by the same procedure used to prepare 17a; IR: 1672, 
1525. 1351 cm·1; 1H NMR: o 7.79 (dd, 1 H, J = 8.5, 1.6), 7.48-7.42 (complex, 3 H), 7.37-
7.25 (complex. 3 H), 7.01-6.96 (complex, 2 H), 5.42 (s, 1 H), 5.22 (s, 1 H), 4.17 (t, 2 H, J 
= 7.1 ). 3.06 (t. 2 H, J= 7.1); 13C NMR: o 152.1, 146.0, 143.7, 140.2, 133.9, 128.5, 127.7, 
126.1. 125.5. 120.3, 115.2, 114.6, 68.3, 34.9; MS: mlz 269 (MJ. 
Anal. Calcd. for C16H15N03: C, 71.38; H, 5.58; N, 5.20. Found: C, 71.25; H, 
5.53~ N. 5.26. 
3-Butenylamine (29a). This compound (3.15 g, 48%) was prepared by reduction 
of 90 mmoles of 27a according to the procedure of Jacobson and Williard,36 bp 75-77° 
(literature41 bp 75-77°); IR: 3372, 3301, 1640, 991,908 cm·1; 1H NMR: o 5.78 (ddt, 1 H, 
J= 17.2, 10.3, 6.9), 5.10 (dm, 1 H,J= 17.2), 5.07 (dm, 1 H,J= 10.3), 2.76 (t, 2 H.J= 
6.6), 2.20 (apparent q, 2 H, J = 6.6), I. 13 (br s, 2 H); 13C NMR: o 136.2, 116.6, 41.2. 
38.1. 
3-Methyl-3-butenylamine (29b). This compound (5.01 g, 64%) was prepared by 
reduction of 90 mmoles of 27b35 according to the procedure of Jacobson and Williard,36 
bp 93-95°; IR: 3365, 3290, 1647, 885 cm·1; 1H NMR: o 4.84 (m, 1 H), 4.76 (m, 1 H) .. 2.84 
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(t .. 2H .. .J = 6.6). 2.20 (t, 2 H, J= 6.6), 1.76 (m, 3 H), 1.15 (br s, 2 H); 13C NMR: 6 143.2, 
111.7 .. 41.9 .. 39.7 .. 22.1. 
N-(3-Butenyl)benzamide (32a). This compound was prepared on an 82-mmole 
scale by Schotten-Baumann benzoylation of 3-butenylamine in benzene using the 
procedure of Dewar and co-workers.37 The product was isolated in 94% yield by column 
chromatography on silica gel eluted with 25% ether in hexanes. The spectral data 
matched those reported previously.42 
N-(3-Methyl-3-butenyl)benzamide (32b). This compound (3.27 g, 96%) was 
isolated by the same procedure used to prepare 32a; IR: 3310, 1639, 1542, 889 cm-1; 1H 
NMR: 8 7.74 (dd, 2 H .. J= 8.1, 1.3), 7.55-7.39 (complex, 3 H), 6.19 (br s, I H), 4.88 (m, 
1 H) .. 4.82 (m. 1 H), 3.58 (apparent q, 2 H, J = 6.8), 2.34 (t, 2 H, J = 6. 7), I. 79 (s, 3 H); 
13C NMR: 6 167.3, 142.7, 134.7, 131.3, 128.5, 126.8, 112.6, 37.3, 37.2, 21.9; MS: mlz 
189 (M+). 
Anal. Calcd. for C12H15NO: C, 76.19; H, 7.94; N, 7.41. Found: C, 76.04; H, 
7.99; N, 7.35. 
Representative Procedure for Nucleophilic Aromatic Substitution of 
Benzamides to 2-Fluoro-1-nitrobenzene: N-(3-Butenyl)-N-(2-nitrophenyl)benzamide 
(34a ). In a 250-mL, three-necked round-bottomed flask equipped with an addition 
funnel, a magnetic stir bar and a condenser, 0.44 g of 60% sodium hydride in mineral oil 
(11.0 mmoles) was washed with hexane (three times) and suspended in 15 mL of 
dimethylformamide. Stirring was started and a solution of 1.75 g (10.0 mmoles) of 32a 
in 15 mL of dimethylformamide was added dropwise at room temperature. The mixture 
was stirred for 2 h at which time a solution of 0.71 g (5.0 mmoles) of 2-tluoro-1-
35 
nitrobenzene in 2 mL of dimethylformamide was added. The reaction became warm and 
turned brown in color. The reaction was stirred for 1 hat room temperature and for 24 h 
at 50° .. then cooled, added to ammonium chloride, and extracted with ether (three times). 
The combined ether layers were washed with water and saturated sodium chloride, dried 
(magnesium sulfate), and concentrated under vacuum. The crude product was flash 
chromatographed on a 40 cm x 2 cm silica gel column eluted with 10-20% ether in 
hexane to afford 1.72 g (58%) of 34a as a yellow oil; IR: 1657, 1528, 1348, 994, 918 
cm- 1~ 1H NMR (not coalesced): 6 7.83 (br s, 1 H), 7.50 (br s, 1 H), 7.43-7.20 (br m, 6 H), 
7.16 (br s .. 1 H) .. 5.79 (hrs, 1 H), 5.09 (hr d, 1 H, J= 16.1), 5.05 (br d, 1 H, J= 9.6), 4.32 
(br s .. 1 H) .. 3.55 (m, 1 H), 2.47 (hrs, 2 H); 13C NMR: 6 165.6, 146.0, 137.5, 134.9, 133.7, 
131.8, 129.9, 128.2 (2), 127.9 (2), 125.7, 117.1, 49.1, 32.l; MS: mlz 296 (~). 
Anal. Calcd. for C11H 16N20 3: C, 68.92; H, 5.41; N, 9.46. Found: C, 69.10; H, 
5.49; N .. 9.33. 
N-(3-Methyl-3-butenyl)-N-2-nitrophenyl)benzamide (34b ). This compound 
( 1.61 g, 52%) was isolated as a light yellow solid by the same procedure used to prepare 
34a, mp 65-66°; IR: 1653, 1529, 1348, 894 cm-1; 1H NMR (not coalesced): 6 7.84 (br s, 1 
H), 7.51 (hrs, 1 H), 7.45-7.23 (hr m, 6 H), 7.14 (hrs, 1 H), 4.79 (br s, 1 H), 4.73 (br s, 1 
H), 4.38 (br s, 1 H), 3.59 (m, 1 H), 2.41 (br s, 2 H), 1.75 and 1.73 (2 s, 3 H); 13C NMR: 8 
168.4, 145.8, 142.6, 135.3, 133.7, 131.9, 130.0, 128.2 (2), 128.0 (2), 125.7, 112.1, 49.1, 
35.4., 22.5; MS: mlz 310 (M+). 
Anal. Calcd. for C1 8H18N20 3: C, 69.68; H, 5.81; N, 9.03. Found: C, 69.79; H .. 
5.87; N, 8.96. 
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Representative Ozonolysis Procedure: 3-(2-Nitrophenoxy)propanal (18a). A 
solution of 0.80 g (4.14 mmole) of 17a in 125 mL of methanol was cooled to -78° and 
treated with ozone until TLC indicated complete consumption of the starting material. 
Excess ozone was purged with a stream of dry nitrogen and the reaction was quenched at 
-78° by addition of 5.08 g (84.9 mmole) of dimethyl sulfide and 200 mg of p-
toluenesulfonic acid. The resulting solution was warmed to room temperature and stirred 
for 8 hours .. then concentrated under reduced pressure. The crude reaction mixture was 
diluted with ether. washed with sodium bicarbonate and sodium chloride, and dried 
(magnesium sulfate). Vacuum filtration and concentration under reduced pressure gave a 
mixture of the aldehyde and its dimethyl acetal. This mixture was dissolved in 25 mL of 
tetrahydrofuran, cooled to 0°, and 25 mL of 3% aqueous perchloric acid was added 
dropwise with stirring.29 The solution was stirred at 0° for I hour and at room 
temperature for 4 hours, then extracted with dichloromethane (three times). The 
combined organic extracts were washed with sodium bicarbonate (two times) and sodium 
chloride, dried (magnesium sulfate), and concentrated under reduced pressure to yield 
0. 76 g (94%) of 18a, which was used without further purification; IR: 2840, 2730., 1723, 
1528, 1354 cm-1; 1H NMR: 6 9.89 (t, I H,J= I.I), 7.83 (dd, 1 H,J= 8.1, 1.8)., 7.55 (ddd, 
1 H, J= 8.4, 7.4, 1.8), 7.13 (dd, I H,J= 8.4, 1.0), 7.06 (ddd, I H,J= 8.1, 7.4, 1.2), 4.44 
(t, 2 H, J = 6.2), 3.02 (td, 2 H, J = 6.2, I.I); 13C NMR: 6 199.2, 151.8, 140.1, 134.1, 
125.6, 120.9, 114.8, 63.4, 42.8; MS: m/z 195 (M+). 
Anal. Calcd. for C9H9N04: C, 55.38; H, 4.62; N, 7.18. Found: C, 55.51; H, 4. 72; 
N, 7.05. 
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4-(2-Nitrophenoxy)-2-butanone (18b). This compound (0.77 g, 95%) was 
isolated by the same procedure used to prepare 18a and purified by flash column 
chromatography on silica gel using 5-10% ether in hexanes. The product was a light 
yellow oil that solidified on cooling to 0°, mp 35-36°; IR: 1717, 1523, 1353 cm-1; 1H 
NMR: 8 7.82 (dd. 1 H, J= 8.1, 1.8), 7.53 (tm, 1 H, J= 8.4), 7.12 (dd, 1 H, J= 8.4, 1.0), 
7 .03 ( ddd. 1 H. J = 8.1, 7.4, 1.2), 4.3 7 (t, 2 H, J = 6.2), 2.98 (t, 2 H, J = 6.2), 2.27 (s, 3 
H)~ 13C NMR: S 206.0, 152.0, 139.8, 134.1, 125.5, 120.6, 114.7, 64.8, 42.3, 30.8; MS: 
mlz 209 (M+). 
Anal. Calcd. for C10H 11N04: C, 57.42; H, 5.26; N, 6.70. Found: C, 57.55, H, 
5.31; N, 6.59. 
1-(2-Nitrophenoxy)-3-heptanone (18c). This compound (0.75 g, 93%) was 
isolated as a light yellow oil by the same procedure used to prepare 18b; IR: 1714, 1527, 
1351 cm·1; 1H NMR: S 7.81 (dd, 1 H, J= 8.1, 1.8), 7.52 (ddd, 1 H, J= 8.5, 7.5, 1.8), 7.12 
(dd. 1 H, J = 8.5, 1.2), 7.03 (ddd, 1 H, J = 8.1, 7.5, 1.2), 4.37 (t, 2 H, J = 6.2), 2.95 (t, 2 
H, J = 6.2), 2.53 (t, 2 H, J = 7.5), 1.60 (quintet, 2 H, J = 7.4), 1.33 (sextet, 2 H, J = 7.4), 
0.92 (t, 2 H, J = 7.4); 13C NMR: S 208.5, 152.0, 140.0, 134.1, 125.5, 120.5, 114.7, 64.9, 
43.5. 41.4, 25.6, 22.2, 13.8; MS: mlz251 (M+). 
Anal. Calcd. for C13H17N04: C, 62.15; H, 6.77; N, 5.58. Found: C, 62.07; H, 
6.75; N, 5.59. 
4,4-Dimethyl-1-(2-nitrophenoxy)-3-pentanone (18d). This compound (0. 73 g, 
91 %) was isolated as a light yellow oil by the same procedure used to prepare 18b; IR: 
1710, 1527, 1354 cm·1; 1H NMR: 6 7.81 (dd, I H, J= 8.2, 1.8), 7.52 (ddd, 1 H, J = 8.4, 
7.4, 1.8), 7.13 (dd, 1 H, J = 8.4, 1.2), 7.02 (ddd, I H, J = 8.2, 7.5, 1.2), 4.39 (t 2 H . .J = 
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6.2). 3.03 (t .. 2 H .. ./= 6.2), 1.19 (s, 9 H); 13C NMR: o 213.0, 152.2, 140.0, 134.1, 125.5, 
120.4. 1 14.6. 65.0. 44.3, 35.8, 26.0 (3); MS (30 electron volts): mlz 251 (MJ. 
Anal. Calcd. for C13H11N04: C, 62.15; H, 6.77; N, 5.58. Found: C, 62.28; H, 
6.83: N. 5.52. 
3-(2-Nitrophenoxy)-l-phenyl-1-propanone (18e). This compound (0.76 g, 
94%) was isolated as a light yellow solid by the same procedure used to prepare 18b, mp 
103-105°: IR: 1684. 1525, 1352 cm·1; 1H NMR: o 8.00 (dd, 1 H, J= 7.1, 1.2), 7.81 (dd, 1 
H . .I= 8. I. 1.8), 7.62-7.45 (complex, 4 H), 7.20 (dd, 1 H, J= 8.4, 1.0), 7.04 (ddd, I H, J= 
8.1.. 7.5.. 1.2). 4.57 (t, 2 H, J = 6.6), 3.55 (t, 2 H, J = 6.6); 13C NMR: o 197 .2, 152.1, 
139.9 .. 136.4, 134.1, 133.5, 128.7, 128.1, 125.5, 120.6, 114.8, 65.1, 42.2; MS: mlz 271 
(M+). 
Anal. Calcd. for C 15H 13N04: C, 66.42; H, 4.80; N, 5.17. Found: C, 66.59; H, 
4.87; N .. 5.05. 
N-(2-Nitrophenyl)-N-(3-oxopropyl)benzamide (35a). This compound (0.66 g, 
82%) was isolated by the same procedure used to prepare 18b. Purification was 
accomplished by flash column chromatography on silica gel eluted with 25% ether in 
hexane to give 35a as a light yellow oil; IR: 2840, 2731, 1719, 1654, 1628, 1348 cm·1; 1H 
NMR (not coalesced): o 9.81 (s, 1 H), 7.82 (d, 1 H, J = 7.2), 7.59 (t, I H, J = 7.5), 7.39 
(apparent t, 2 H, J= 8.0), 7.30-7.07 (complex, 5 H), 4.36 (m, I H), 4.07 (quintet, 1 H, J= 
6.6) .. 3.03 (br s, 3 H); 13C NMR: o 200.4, 170.6, 146.2, 142.6, 134.4, 1342, 131.2, 130.3, 
128.4, 128.2, 128.0, 125.7, 45.0, 42.l; MS: mlz 298 (MJ. 
Anal. Calcd. for C16H 14N20 4: C, 64.42; H, 4.70; N, 9.40. Found: C, 64.61: H. 
4.82; N, 9.27. 
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N-(2-Nitrophenyl)-N-(3-oxobutyl)benzamide (3Sb). This compound (0.68 g, 
84%) was isolated as a light yellow solid by the same procedure used to prepare 35a, mp 
62-64°; IR: 1711, 1654, 1528, 1348 cm·1; 1H NMR (not coalesced): o 7.78 (d, 1 H, J = 
7.2). 7.60 (t 1 H .. J= 7.2), 7.44 (dd, 1 H, J= 8.0, 1.3), 7.34 (t, 1 H, J= 7.5), 7.31-7.05 
( complex. 5 H), 4.20 (m, 1 H), 4.12 (m, 1 H), 3.05 (hrs, 2 H), 2.16 (br s, 3 H); 13C NMR: 
8 208.0. 170.3. 145.7, 138.1, 134.5, 134.1, 131.0, 130.2, 128.3, 128.1, 127.9, 125.7, 46.5, 
41.2. 30.0; MS: mlz 312 (M+). 
Anal. Calcd. for C11H 16N20 4: C, 65.38; H, 6.09; N, 8.97. Found: C, 65.47; H, 
6.13; N .. 8.93. 
Representative Procedure for Reductive Ring Closure: 2,3,4,5-Tetrahydro-
1,5-benzoxazepine (Sa). To a solution of 750 mg (3.85 mmole) of 18a in 300 mL of 
methanol was added 150 mg of 5% palladium-on-carbon and the mixture was 
hydrogenated in a stainless steel hydrogenation vessel under 4 atmospheres of hydrogen 
for 3 hours at 25°. The crude reaction mixture was concentrated, diluted with ether, and 
vacuum filtered through a pad of Celite 545® topped with a layer of magnesium sulfate to 
remove the catalyst. Concentration of the filtrate produced a light yellow oil that was 
purified by preparative thin layer chromatography eluted with increasing concentrations 
of ether in hexanes ( 10%) to give 4 70 mg (82%) of Sa as a light yellow oil which 
solidified on standing at O°, mp 35-37°; IR: 3358 cm·1; 1H NMR: 6 6.96 (dd, 1 H, J = 7.8, 
1.6). 6.87 (td, 1 H, J = 7.4, 1.6), 6.79 (td, 1 H, J = 1.5, 1.8), 6. 72 (dd, 1 H, J = 7.5, 1.8), 
4.08 (t, 2 H" J = 5.4), 3.77 (hrs, 1 H), 3.24 (t, 2 H, J = 5.6), 2.00 (m, 2 H); 13C NMR: 6 
150.2, 142.0., 123.4, 121.9, 120.9, 119.6, 71.5, 46.0, 31.9; MS: mlz 149 (M+). 
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Anal. Calcd. for C9H11NO: C, 72.48; H, 7.38; N, 9.40. Found: C, 72.63; H, 7.46; 
N. 9.32. 
When the reductive ring closure was run under more concentrated conditions 
(3.85 x 10-2 M). Sa was produced in 72% yield and dimer 36 was isolated in 3.5% yield, 
mp 254-256°: IR: 3426 cm-1; 1H NMR: o 6.88 (td, 2 H, J= 7.7, 1.3), 6.72 (dd, 2 H, J = 
8.0. 1.3) .. 6.65 (td, 2 H, J= 7.7, 1.5), 6.58 (dd, 2 H, J= 8.0, 1.5), 5.13 (br s, 2 H), 4.21 (t, 
4 H . ./ = 5.0). 3.35 (q .. 4 H, J = 5.0), 2.29 (quintet, 4 H, J = 5.1); 13C NMR: o 145.9, 
138.0. 121.3 .. 116.3. 109.4, 108.7, 69.5, 44.5, 27.9; MS: mlz 298 (M+). 
Anal. Calcd. for C1sH22N20 2: C, 72.48; H, 7.38; N, 9.40. Found: C, 72.54; H, 
7.39: N .. 9.33. 
(±)-4-Methyl-2,3,4,S-tetrahydro-1,5-benzoxazepine (Sb). This compound was 
isolated by the same procedure used to prepare 5a. The resulting oil (473 mg, 87%) 
crystallized at 0° to a yellow solid that darkened on exposure to air, mp 60-62°; IR: 3351 
cm- 1; 1H NMR: o 6.93 (dd, 1 H, J = 7.5, 1.6), 6.85 (td, 1 H, J = 7.4, 1.6), 6.76 (td, 1 H, J 
= 7.5, 1.8), 6.71 (dd, 1 H, J= 7.5, 1.8), 4.38 (ddd, 1 H, J= 12.1, 6.2, 3.8), 3.79 (ddd, 1 H, 
J = 11. 9., 8.2., 3.5), 3.32 (m, 1 H), 3.32 (br s, 1 H), 1.96 (ddt, 1 H, J = 13.8, 6.3, 3.4), 1. 78 
(m .. 1 H), 1.29 (d, 3 H, J = 6.5); 13C NMR: o 150.3, 140.8, 123.3, 121.7, 120.9, 119.8, 
70.6., 51.6., 39.4, 22.9; MS: m/z 163 (M+). 
Anal. Calcd. for C10H13NO: C, 73.62; H, 7.98; N, 8.59. Found: C, 73.68; H, 
8.02; N, 8.56. 
(±)-4-Butyl-2,3,4,5-tetrahydro-1,5-benoxazepine (Sc). This compound was 
isolated by the same procedure used to prepare 5a and purified by preparative thin layer 
chromatography eluted with 10% ether in hexanes. The resulting oil (370 mg. 90%) 
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H NMR: 5 6.92 ( dd, 1 H, J= 7.7, 1.6), 6.85 (td, 1 H, J= 7.4, 1.6), 6.76 (td, 1 H, J 
= 7.5. I .8). 6.70 (dd, 1 H. J= 7.5, 1.8), 4.39 (ddd, 1 H, J= 12.1, 7.1, 3.7), 2.02 (ddt, 1 H, 
.I= 10.6. 7.1. 3.7). 1.74 (dddd, 1 H, J= 13.8, 11.1, 7.4, 3.8), 1.57 (m, 2 H), 1.47-1.28 
(complex. 4 H). 0.93 (t, 3 H, J = 6.9); 13C NMR: o 150.1, 140.7, 123.1, 121.4, 120.8, 
I 19.7. 70.3. 55.8. 37.4. 36.3, 28.4, 22.7, 14.0; MS: mlz 205 (Ml. 
Anal. Calcd. for C13H 19NO: C, 76.10; H, 9.27; N, 6.83. Found: C, 76.02; H, 
9.23: N. 6.85. 
(±)-4-tert-Butyl-2,3,4,5-tetrahydro-1,5-benzoxazepine (5d). When the 
procedure for 5a was run on 300 mg ( 1.20 mmole) of 18d, 240 mg of a mixture of Sd and 
37 resulted. Purification by preparative thin layer chromatography eluted with I 0% ether 
in hexanes afforded two bands. Band 1 (fastest moving) contained 90 mg (37%) of Sd 





H NMR: o 6.87 (dd, 1 H, J = 7.7, 1.6), 6.83 (td, 1 H, J = 7.5, 1.6), 6.73 
(td, I H, J = 7.5, 1.8), 6.66 (dd, 1 H, J= 7.5, 1.8), 4.46 (ddd, 1 H, J= 11.9, 8.2, 3.5), 3.96 
(ddd, 1 H. J= 11.9, 5.6, 4.6), 3.38 (br s, 1 H), 3.07 (dd, 1 H, J= 11.1, 3.5), 2.06 (dddd, 1 
H. J= 13.5, 11.9, 4.6, 3.5), 1.77 (dddd, 1 H,J= 13.5, 11.1, 5.6, 4.0), 1.02 (s, 9 H); 13C 
NMR: o 149.7, 140.8, 122.8, 120.8, 120.4, 119.0, 70.3, 64.6, 33.8, 31.8, 26.4 (3); MS (30 
electron volts): mlz 205 (M+). 
Anal. Calcd. for C13H 19NO: C, 76.10; H, 9.27; N, 6.83. Found: C, 76.17; H, 
9.29; N, 6.80. 
l-(2-Aminophenoxy)-4,4-dimethyl-3-pentanone (37). This compound ( 130 mg .. 
49%) was isolated as a light yellow oil from Band 2 (above). This oil solidified at 0° to a 
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light yellow solid that darkened on exposure to air, mp 37-38°; IR: 3468, 3372, 1704 
cm- 1~ 11-1 NMR: 8 6.81 (m, 2 H), 6.70 (m, 2 H), 4.26 (t, 2 H, J = 6.3), 3.75 (br s, 2 H), 
2.99 (t. 2 H. J= 6.3), 1.18 (s, 9 H); 13C NMR: 8 213.5, 146.2, 136.6, 121.6, 118.4, 115.2, 
I I 2.6. 63.9. 44.3. 36.2, 26.1 (3); MS (30 electron volts): mlz 221 (M+). 
Anal. Calcd. for C13H19N02: C, 70.59; H, 8.60; N, 6.33. Found: C, 70.78; H, 
8.69; N. 6. I 9. 
(±)-3-(2-Aminophenoxy)-1-phenyl-1-propanol (38). When the reductive 
eye I ization was carried out on 400 mg of 18e by the same procedure used to prepare 5a, 
300 mg (84%) of 38 was isolated as an oil that crystallized to a tan solid at 0°. Trituration 
of the solid with I% ether in petroleum ether gave 38 as a light tan solid, mp 55-56°; IR: 
3360 cm·1; 11-1 NMR: 8 7.40-7.20 (complex, 5 H), 6.82-6.65 (complex, 4 H), 4.97 (dd, 1 
H .. .J= 7.8. 5.l),4.16(ddd, 1 H,J=9.6, 7.l,5.3),4.04(m, 1 H),3.30(brs,3 H),2.21 (m, 
2 H); 13C NMR: 8 146.4, 144.2, 136.2, 128.5, 127.6, 125.8, 121.4, 118.6, 115.2, 111.9, 
71.9. 65.5., 38.5; MS: mlz 243 (M+). 
Anal. Calcd. for C 15H17N02 : C, 74.07; H, 7.00; N, 5.76. Found: C, 74.22; H, 
7.07; N, 5.65. 
(±)-l-Benzoyl-2,3,4,5-tetrahydro-lH-1,5-benzodiazepine (6a). This compound 
( 625 mg., 82%) was isolated as a white solid by the same procedure used to prepare 5a., 
mp 137-138°; IR: 3338, 1632 cm-1; 1H NMR (not coalesced): 8 7.26 (d, 2 H, J = 6.8)., 
7.23-7.07 (complex, 3 H), 6.93 (td, 1 H, J= 8.0, 1.5), 6.76 (dd, 1 H, J= 8.0, 1.2), 6.54 (d, 
1 H, J = 6.8)" 6.50 (t, 1 H, J = 7.2), 5.10 and 5.06 (2 hrs, 1 H), 3.96 (br s, 1 H), 3.58 (br s, 
1 H)., 3.01 (t, I H,J= 10.3),2.89(t, 1 H,J= 10.3),2.lO(brs, 1 H), 1.97(brs, 1 H); 13C 
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NMR: 8 169.7 .. 145.7 .. 136.5, 134.0, 129.7, 129.3, 127.9, 127.7, 127.5, 120.5, 119.5, 46.1 
(2) .. 29.5: MS: mlz 252 (M+). 
Anal. Calcd. for C 16H16N20: C, 76.19; H, 6.35; N, 11.11. Found: C, 76.23; H, 
6.38: N .. 11.06. 
(±)-l-Benzoyl-4-methyl-2,3,4,5-tetrahydro-lH-1,5-benzodiazepine (6b ). This 
compound ( 450 mg .. 88%) was isolated as a white solid by the same procedure used to 
prepare Sa .. mp 124-125°; IR: 3325, 1632 cm-1; 1H NMR (not coalesced): o 7.37 (br s, 1 
H) .. 7.30-7.03 (complex, 3 H), 6.96 (d, 1 H, J= 7.2), 6.83 (d, 1 H, J= 7.5), 6.59 (br s, 2 
H). 5.13 and 5.19 (2 br s, 0.67 H), 4.82 (br s, 0.33 H), 4.03 (br s, 0.33 H), 3.55 (br s, 0.67 
H) .. 3.40 (br s, 0.33 H), 3.08 (br s, 0.67 H), 2.71 (br s, 0.67 H), 2.27 (br s, 0.33 H), 1.84 
(br s .. 2 H) .. 1.37 (d, 3 H, J = 6.0), 1.27 (br s, 1 H); 13C NMR: o 169.5, 145.4, 136.5, 
136.0 .. 129.5., 129.3, 128.4, 127.7, 127.5, 120.8, 118.2, 53.1, 45.4, 37.6, 23.8; MS: mlz 
266 (M+). 
Anal. Calcd. for C17H18N20: C, 76.69; H, 6.77; N, 10.52. Found: C, 76.74; H, 
6.79; N., 10.47. 
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